|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, June 29, 2017 ) Ovarian cancer, or cancer of the ovaries, is one of the most common types of cancer in women. The ovaries are a pair of small organs located low in the tummy that are connected to the womb and store a woman's supply of eggs. Ovarian cancer mainly affects women who have been through the menopause (usually over the age of 50), but it can sometimes affect younger women.
The symptoms of ovarian cancer can be difficult to recognise, particularly early on.
They're often the same as symptoms of less serious conditions, such as irritable bowel syndrome (IBS) or pre-menstrual syndrome (PMS). Ovarian cancer occurs when cells in the ovaries grow and multiply uncontrollably, producing a lump of tissue called a tumour. It's not clear exactly why this happens, but the following factors may increase your risk of getting ovarian cancer.
The treatment for ovarian cancer depends on how far it has spread, your general health and whether you're still able to have children. Most people have a combination of surgery and chemotherapy. The aim of treatment is to cure the cancer if possible. If the cancer is too advanced to be cured, treatment aims to relieve symptoms and control the cancer for as long as possible.
Get a comprehensive overview of the Global Ovarian Cancer Therapeutics market: http://www.marketdataforecast.com/market-reports/global-ovarian-cancer-therapeutics-market-1468/
Global Ovarian Cancer Therapeutics Market: Drivers & Restraints
Cases of ovarian cancer have grown rapidly, as a result, so has its therapeutics market. One of the factors is increase in aging of the women population. Introduction of new drugs and effective therapies, increase in people’s disposable income, and better government funding and support are some of the key factors behind the growth of global ovarian cancer market. Additionally, increasing awareness about healthcare is also propelling the growth of the ovarian cancer market. Recent launches of generic drugs, and expiration of patents of blockbuster drugs, such as Taxol, Gemzar, Paraplatin and Hycamtin are some of the key factors restraining the growth for ovarian cancer market..
Get accurate market forecast and analysis on the Global Ovarian Cancer Therapeutics market. Request a sample to stay up-to-date on the main trends affecting this market http://www.marketdataforecast.com/market-reports/global-ovarian-cancer-therapeutics-market-1468/request-sample
Global Ovarian Cancer Therapeutics market: Segmentation
Stage Of Cancer
• Stage I
• Stage II
• Stage III
• Stage IV
Type
• Primary Peritoneal Carcinoma
• Ovarian Stromal Tumors
• Ovarian Germ Cell Tumors
• Epithelial Ovarian Tumors
Diagnosis
• Physical Examination
• Blood Tests
• Ultrasound
• PET
• CT Scan
• MRI
• Human Chorionic Gonadotropin Test
• Biopsy
Treatment
• Chemotherapy
• Radiation Therapy
• Hormonal Therapy
• Surgery
• Immunotherapy
• Targeted Therapy
From simple data collation through secondary and primary research toad-hoc research requests relating to specific information, we provide our services via customization.
Get customization at http://www.marketdataforecast.com/market-reports/global-ovarian-cancer-therapeutics-market-1468/customize-report
Global Ovarian Cancer Therapeutics market: Overview
The current Ovarian cancer therapeutics market is dominated by the use of generics – predominately carboplatin and paclitaxel, which are used in combination for the treatment of platinum-sensitive disease (both first-line and recurrent). Initial treatment with platinum-based therapy is usually effective, with approximately 70% of patients entering remission. However, even with extended progression free-survival of 24 months, almost all patients relapse, and after successive periods of remission and relapse either die or progress to platinum-resistant disease, for which the prognosis is poor. There is a clear gap in the market for maintenance therapies to extend the initial high rates of remission, and hopefully stimulate long-term remission in patients. As well as a gap for more effective treatment options in platinum-resistant or refractory patients.
Despite the poor results obtained with late stage pipeline drugs there is evidence of continued interest in the ovarian cancer market, with a high number of drug candidates in the current developmental pipeline, particularly at the Preclinical Phase. There is a wide range of novel molecular targets distributed amongst these drug candidates, including growth factors, serine/threonine protein kinases and tumor associated antigens. This suggests a continued interest in introducing more targeted therapies into the treatment of OC, the use of which in this indication lags significantly behind that in other indications in oncology.
Global Ovarian Cancer Therapeutics market: Region-wise Outlook
On the basis of geography, the global market is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. North American region, in particular, US is the largest market for Ovarian cancer. Europe is the second largest market as the cases of ovarian cancer are very high too..
Key Questions Answered
• What is the current and future Ovarian Cancer Therapeutics market outlook worldwide? What trends are affecting the Global market?
• What is the competitive landscape and market share of major players in the Ovarian Cancer Therapeutics space globally?
• What are the key, high growth markets that Ovarian Cancer Therapeutics should expand into? Which market segments are growing the fastest?
• What are the unmet needs with the Ovarian Cancer Therapeutics currently on the market? How will emerging technologies fulfil these unmet needs?
• What is physician perception and market outlook of Ovarian Cancer Therapeutics?
• What are the challenges and barriers that have hindered widespread adoption of Ovarian Cancer Therapeutics?
Global Ovarian Cancer Therapeutics market: Key Players
Some of the major players in this market are Aetera Zenteris Inc., Eli Lilly and Company, Roche, Amgen, Janssen Pharmaceuticals, Inc., Bristol Myers Squibb Company, Novogen, Inc., GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca and Genentech Inc.
Reasons to buy Ovarian Cancer Therapeutics market Report:
•Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
• Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
•Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
•Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
•A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
•Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
•Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Therapeutics Segment:
Clinical Nutrition Market: http://www.marketdataforecast.com/research-reports/healthcare/therapeutics-11/market-reports/global-clinical-nutrition-market-785/
Colorectal Cancer Market: http://www.marketdataforecast.com/research-reports/healthcare/therapeutics-11/market-reports/global-colorectal-cancer-market-612/
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
